Simulations Plus (NASDAQ: SLP)
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-10-24 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.170 | 0.200 | 0.0300 | ||||
REV | 14.330M | 14.959M | 629.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Simulations Plus (NASDAQ: SLP) through any online brokerage.
Other companies in Simulations Plus’s space includes: Change Healthcare (NASDAQ:CHNG), MultiPlan (NYSE:MPLN), GoodRx Holdings (NASDAQ:GDRX), OptimizeRx (NASDAQ:OPRX) and Pear Therapeutics (NASDAQ:PEAR).
The latest price target for Simulations Plus (NASDAQ: SLP) was reported by Craig-Hallum on Thursday, July 7, 2022. The analyst firm set a price target for 60.00 expecting SLP to fall to within 12 months (a possible -10.29% downside). 2 analyst firms have reported ratings in the last year.
The stock price for Simulations Plus (NASDAQ: SLP) is $66.88 last updated August 5, 2022, 8:00 PM UTC.
A quarterly cash dividend of $0.06 per share of Class A Common Stock. The quarterly cash dividend was payable on August 1, 2022 to stockholders of record on July 22, 2022.
Simulations Plus’s Q4 earnings are confirmed for Monday, October 24, 2022.
There is no upcoming split for Simulations Plus.
Simulations Plus is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.